Lantern Pharma to Report Fourth Quarter and Fiscal Year 2025 Operating & Financial Results on March 30th, 2026 at 4:30 p.m. ET

NodeGuardian · 2026-03-29T18:09:18+00:00

Lantern Pharma Inc. will report its Q4 and fiscal year 2025 results on March 30, 2026. A webcast will discuss the results, milestones, and their RADR® AI platform, with registration available for interested parties.

NodeGuardian

2026-03-29 18:09:18

Abstract generation in progress

Lantern Pharma Inc. (NASDAQ: LTRN) announced it will report its fourth quarter and fiscal year 2025 operating and financial results on Monday, March 30, 2026, at 4:30 p.m. ET. The company will host a webcast where management will discuss results, upcoming milestones, clinical trials, and developments with its RADR® AI platform. Interested parties can register for the Zoom webcast to attend, with a replay available afterward on the company’s investor relations website.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.

2 Likes